Operational tolerance to class I disparate lungs can be induced despite pretransplant immunization with class I allopeptides

Transplantation. 2007 Dec 15;84(11):1467-73. doi: 10.1097/01.tp.0000288321.67926.13.

Abstract

Background: Using a class I-disparate swine lung transplant model, we examined whether an intensive course of tacrolimus could induce operational tolerance and whether preoperative allopeptide immunization would prevent the development of tolerance.

Methods: Left lung grafts were performed using class I-disparate (class II-matched) donors. Recipients were treated with 12 days of postoperative tacrolimus. Three recipients were immunized prior to transplantation with class I allopeptides. Three other recipients were not immunized.

Results: The nonimmunized recipients maintained their grafts long term (>497, >451, and >432 days), without developing chronic rejection. The immunized swine also maintained their grafts long term (>417, >402, >401 days), despite developing a variety of in vitro and in vivo responses to the immunizing peptides, as well as having strong mixed lymphocyte reactions to donor cells prior to transplantation.

Conclusions: Using only a brief course of tacrolimus, we have been able to induce a state of operational tolerance in a class I-disparate preclinical lung transplant model. Moreover, preoperative alloimmunization did not block tolerance induction or induce chronic rejection. These data show that it is possible to create a state of operational tolerance to lung allografts even in the presence of donor-sensitized cells.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Graft Survival / immunology
  • Histocompatibility Antigens Class I / immunology*
  • Hypersensitivity / immunology
  • Immune Tolerance / drug effects
  • Immune Tolerance / immunology*
  • Lung Transplantation / immunology*
  • Peptides / immunology*
  • Skin Transplantation / immunology
  • Swine
  • Swine, Miniature
  • Tacrolimus / pharmacology
  • Time Factors
  • Transplantation, Homologous / immunology

Substances

  • Histocompatibility Antigens Class I
  • Peptides
  • Tacrolimus